Find courses

Find reading lists, lecture times and notes from all courses from the department.


Search for staff and students

Services and tools


Our researchers in the media

  • Poly(I:C)-Encapsulating Nanoparticles Enhance Innate Immune Responses to the Tuberculosis Vaccine Bacille Calmette–Guérin (BCG) via Synergistic Activation of Innate Immune Receptors Oct. 19, 2017 10:13 PM
    Martin T. Speth†, Urska Repnik†, Elisabeth Müller† ‡, Julia Spanier§, Ulrich Kalinke§, Alexandre Corthay‡, and Gareth Griffiths* † † Department of Biosciences, University of Oslo, N-0371 Oslo, Norway ‡ Tumor Immunology lab, Department of Pathology, Rikshospitalet, Oslo University Hospital and University of Oslo, N-0424 Oslo, Norway § Institute for Experimental Infection Research, TWINCORE, Center for Experimental and Clinical Infection Research, a joint venture between the Helmholtz Centre for Infection Research, Braunschweig, and the Hannover Medical School, D-30625 Hannover, Germany Mol. Pharmaceutics, Article ASAP DOI: 10.1021/acs.molpharmaceut.7b00795 Publication Date (Web): October 3, 2017 Copyright © 2017 American Chemical Society *E-mail: g.w.griffiths@ibv.uio.no. Phone: +47 22 85 7582.
  • Dünya Üzerinde Kaç Dinozor Türü Yaşadı? Oct. 10, 2017 8:06 PM
    Bugün Dünya üzerinde yaklaşık 10.000 kuş türü yaşamaktadır. Bugün yaşayan kuşların dinozor soylarının devamı olduğu düşünülecek olursa, bugün yaşayan
  • ​Melting sea ice may open polar oceans to new predators Oct. 5, 2017 11:54 AM
    Melting sea ice may open polar oceans to new predators
  • Albumedix, Oslo University Hospital and University of Oslo establish strategic research collaboration Oct. 5, 2017 8:03 AM
    Albumedix has announced that it has signed a strategic research agreement with Oslo University Hospital and University of Oslo. The three organisations will work together to improve understanding of the interaction between bioengineered albumin variants and the neonatal Fc receptor (FcRn). The aim will be to establish an in-depth molecular, cellular and in vivo understanding on how FcRn acts as a key player in homeostatic regulation of albumin and albumin-based therapeutics using state-of-the-art technologies and animal models.




Hiring research infrastructure


Our research facilities can be hired if you have need for the specialized equipment at the department.